CD3X anti-nitrophenyl bispecific diabodies: universal immunotherapeutic tools for retargeting T cells to tumors.
Manzke O, Fitzgerald KJ, Holliger P, Klock J, Span M, Fleischmann B, Hescheler J, Qinghua L, Johnson KS, Diehl V, Hoogenboom HR, Bohlen H.
Manzke O, et al.
Int J Cancer. 1999 Aug 27;82(5):700-8. doi: 10.1002/(sici)1097-0215(19990827)82:5<700::aid-ijc13>3.0.co;2-2.
Int J Cancer. 1999.
PMID: 10417768
Free article.